Development of a FLIPR Assay for the Simultaneous Identification of MrgD Agonists and Antagonists from a Single Screen
Authors:
Open Access
- 14 September 2010
- journal article
- research article
- Published by Wiley in Journal of Biomedicine and Biotechnology
- Vol. 2010, 1-8
Abstract
MrgD, a member of the Mas-related gene family, is expressed exclusively in small diameter neurons in the dorsal root ganglion. This unique expression pattern, the presence of a single copy of MrgD in rodents and humans, and the identification of a putative ligand, beta-alanine, make it an experimentally attractive therapeutic target for pain with limited likelihood of side effects. We have devised a high throughput calcium mobilization assay that enables identification of both agonists and antagonists from a single screen for MrgD. Screening of the Library of Pharmacologically Active Compounds (LOPAC) validated this assay approach, and we identified both agonists and antagonists active at micromolar concentrations in MrgD expressing but not in parental CHO-DUKX cell line. Further characterization was performed using a subset of these screening hits. Our results demonstrated that the dual agonist/antagonist assay format is feasible and likely can be extended to most GPCRs with known agonist.Keywords
This publication has 36 references indexed in Scilit:
- Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuliProceedings of the National Academy of Sciences, 2009
- Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonistsActa Pharmacologica Sinica, 2007
- Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonistsActa Pharmacologica Sinica, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Topographically Distinct Epidermal Nociceptive Circuits Revealed by Axonal Tracers Targeted to MrgprdNeuron, 2005
- The glycine receptorPharmacology & Therapeutics, 1997
- The use of chlorpromazine for symptom control in dying cancer patientsJournal of Pain and Symptom Management, 1994
- Chlorpromazine Inhibits Both the Constitutive Nitric Oxide Synthase and the Induction of Nitric Oxide Synthase After LPS ChallengeBiochemical and Biophysical Research Communications, 1993
- Dual activation of GABAA and glycine receptors by β-alanine: inverse modulation by progesterone and 5α-pregnan-3α-ol-20-oneEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- DISTRIBUTION OF AMINO ACIDS AND OF EXO‐ AND ENDOPEPTIDASES ALONG VERTEBRATE AND INVERTEBRATE NERVESJournal of Neurochemistry, 1970